Hi, it's Amber in Hong Kong. Blockbuster weight-loss drug Wegovy is going to be much cheaper in China than it is in the US.

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...

Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

Lilly is aiming to strengthen its position as a leader in the obesity treatment market, which is expected to hit $150 billion ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

With Wegovy gaining acceptance for China in Q2 2024, this opens the door for Novo Nordisk to gain a foothold in a potentially ...

European mega-caps trail US 'Magnificent 7' amid lack of AI gains, while also facing China’s slowdown and rising geopolitical ...

Novo Nordisk rose after the Danish giant launched its Wegovy weight-loss product in China. Merck reported promising trial results for a new, easier-to-administer formulation of its blockbuster cancer ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

The Bank of England said retailers were right to warn of job cuts UK inflation accelerated sharply back up to 2.3% in October ...